Welcome Cure secures US$480K pre-series A financing

Welcome Cure, a fully integrated Homeopathy Technology company, raises $480,4K in pre-series A round led by Inflection Point Ventures (IPV).

The funds will be utilized for growth, including talent acquisition, technology enhancement, and marketing initiatives.

Welcome Cure offers Assisted intelligence (AI)-powered solutions for doctors and patients, ensuring both effective prescriptions and convenient access to healthcare regardless of location and is looking at raising over $1.9 million in this on-going funding round.

Welcome Cure recognizes the surging demand for sustainable and holistic healthcare solutions. In response, the company offers a comprehensive one-stop platform for addressing the fragmented homeopathy market. Their innovative approach includes online and offline services for diagnosis, treatment, and monitoring, with a strong emphasis on preventive care and overall well-being.

Driving Welcome Cure’s vision is a team of accomplished individuals. Dr. Jawahar Shah, the Founder, boasts 45 years of clinical practice as an MD in Homeopathy, and he holds a post-graduate degree from London. Punit Desai, the Co-founder and CEO, contributes his expertise with an MBA and over a decade of entrepreneurship experience. Nidhi Desai, the Co-founder and COO, brings an MBA and similar entrepreneurial experience to the team. Together, they form a strong and visionary leadership that is dedicated to providing holistic healthcare solutions through their innovative platform.

Vikram Ramasubramanian, Partner, Inflection Point Ventures, says, “While Homeopathy treatment is well recognised across the globe, the number of people opting for such treatment is also growing exponentially. The main reason for such acceptance is the ability to provide treatment to the root cause, especially chronic disease which is recurring and needs utmost attention. Welcomecure with its unique healthcare solution has been able to offer its patients the much-needed treatment regardless of location. The brand itself has grown multifolds with its ability to offer seamless interaction between its patients and doctors, onboard best   caregivers and experts in homeopathic medicine and providing a holistic solution all under a roof. We at IPV look forward to scaling their new age business with strategic guidance and enable the brand to benefit more and more individuals”.

Welcome Cure operates at an impressive scale, with 2.5 million platform users and 1.5 million+ registered patients in 36+ countries. Their software business serves over 1 lakh doctors in 140+ countries.

Welcome Cure stands out in the healthcare industry with its modernized homeopathy and holistic care solutions, catering to patients’ needs in a comprehensive manner. Their unique proposition lies in the integration of proprietary Assisted Intelligence (AI) solutions, which serve as a valuable decision support system for physicians. This AI-powered technology enhances diagnostic accuracy, treatment selection, and monitoring, ensuring optimal patient care. Welcome Cure’s commitment to an integrated and 360-degree technology-powered solution further solidifies their position as leaders in the homeopathy domain.

Dr. Jawahar Shah, Founder, Welcome Cure says, “Homeopathy has been around for more than 200 years, grown consistently and served humanity. It enjoys acceptance from all socio-economic classes and has a wide presence across the world. As per WHO it is the 2nd largest system of medicine and used in over 100 countries. In a $9 Billion+ market there is immense potential as it’s growing at over 18% CAGR and there is a missing brand which is a name synonym to Homeopathy. Welcome Cure desires to do that and be that. Emerge as the 1st choice when anyone thinks of Homeopathy Care. With IPVs participation in Welcome Cure as an equity and growth investor we are poised to make this vision come to light.”

Welcome Cure has achieved remarkable organic growth since its inception, with a positive return for the past two years. Within the last couple of years alone, the company has achieved a cumulative business of over 45+ crores, demonstrating its strong presence in the Alternative Medicine space. The startup and its founders have also received recognition and accolades from esteemed institutions and bodies, including testimonials and awards from Prime Minister Narendra Modi, the Ministry of Electronics & IT, and other prestigious organizations.

The Homeopathy industry is currently valued at over 7 billion USD and is experiencing a growth rate of 18% CAGR (Compound Annual Growth Rate). Projections indicate that the industry is expected to surpass 21 billion USD within the next 5 to 7 years, indicating significant growth potential in the near future.